about
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosisThe mechanism of action of PA-824: Novel insights from transcriptional profilingPA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO releaseHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisMeropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosisMechanism-based Inactivation by Aromatization of the Transaminase BioA Involved in Biotin Biosynthesis in Mycobaterium tuberculosisBisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosisStructure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824TB drug development: immunology at the tableA small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosisUnique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosisPrevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyMycolic acids: structure, biosynthesis and physiological functionsProteasomal protein degradation in Mycobacteria is dependent upon a prokaryotic ubiquitin-like proteinEthionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosisReal-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)The ongoing challenge of latent tuberculosisEvaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionRv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificityThe effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosisThe stringent response of Mycobacterium tuberculosis is required for long-term survivalThe 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophagesThe role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in miceIdentification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosisBiosynthesis and recycling of nicotinamide cofactors in mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilliAntitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domainA common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosisThe role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosisThe role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosisIdentification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosisA point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927Expression, production and release of the Eis protein by Mycobacterium tuberculosis during infection of macrophages and its effect on cytokine secretionThe biosynthesis of mycolic acids in Mycobacterium tuberculosis. Enzymatic methyl(ene) transfer to acyl carrier protein bound meromycolic acid in vitroIdentification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisPharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisComparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside ResistanceMycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in miceMolecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis.
P50
Q24538909-8F2B389F-92D0-46AC-86AD-6D979B692E69Q24609567-2E4A78D0-B1AE-469B-8053-29687D65BA4EQ24643238-CFB7139F-8A7E-4380-AD28-863F062E1932Q24654913-F23572D7-F757-4B56-9C2A-5E6C21940E59Q26823503-E5C61B61-F724-43EF-95BF-59920527936BQ27004482-D5DE9D5E-211C-4DF5-BA47-CF1AA1737A35Q27653976-399EBAF3-FD58-460A-AF95-6F0CBCA0F0B4Q27674947-14B7A02D-9E04-4251-A1C6-3C73C13EF80CQ27675807-D4B89F20-63F5-4413-8864-77D29BB57B14Q27676727-4055C569-1A32-4532-80F5-A65AF4B6E6A8Q28083600-D2491AF0-8CC9-4346-B0C3-B2B19F8E1C7CQ28139874-A6B0F5CD-EDF9-422A-B2E5-D6619AEBCBF5Q28210003-37E9B3E4-9363-483A-9E80-E1675BC32CEDQ28273981-A54757A0-6CB6-4B44-A8FF-6C9CDD5DAE43Q28289888-78310235-0FD1-41FD-B45C-0394C8E6FC14Q28301654-622BBB82-ACB8-4F66-A369-38EB02726F73Q28344564-807234C0-0AD7-4171-B229-51396B9AE0A9Q28384972-4A11EA4D-CFCB-44FA-B3A3-C355E2AC1776Q28386135-39DFAC9E-657E-4DCE-9880-FC97CA91A38FQ28477282-8F212626-4F42-4AED-AEEB-C57B6CCC453DQ28477960-9E3FF1B1-0407-4194-BB04-F068DE467276Q28486214-2C52EE5F-9380-4E07-8FB9-7B0C0EB5D97AQ28486427-8270E108-995E-4389-B327-A237F03F7739Q28486738-FBFF9247-0D68-4F97-84EF-F27EDD43CB08Q28486838-F6E6235E-1845-4109-8AD9-17ACA2F78DC9Q28486917-C5CD5073-9DAB-47F4-9248-5E53275CDD1BQ28487010-9A189B9C-65F5-4784-96CA-B7843EB1FF4FQ28487064-4B88E382-226E-4E7F-8434-253238BC2A1AQ28487134-43F008F5-87E7-424D-8A25-F88001B12781Q28487367-8F65B50E-2400-4871-B416-25F3B11ADB49Q28487416-6387ED2A-2781-42DF-AC57-7E3B76490D5CQ28487417-B6DFB706-5E90-4A8F-B09E-BD76D5862C44Q28487455-1DCBAE94-AA57-48E7-8F23-38527C609220Q28487481-E7166BFF-80E9-453B-B220-DBBA411FE8F6Q28487583-15292D07-8F67-48C0-B633-2CD8693581A5Q28533721-E2C65A21-CDCE-4A4E-A942-E1223584A5C5Q28542435-3147AC8B-8746-4569-9F80-BB51F56352D8Q28546999-A90B7A0F-7F30-49E0-A508-ADC9B31FAD85Q28728356-94575E93-97DB-4A35-9EF7-6393D53E8B34Q29568187-AC4D1578-3753-4998-8C47-AD4DE7C3EE4A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clifton E Barry
@ast
Clifton E Barry
@en
Clifton E Barry
@es
Clifton E Barry
@nl
Clifton E Barry
@sl
type
label
Clifton E Barry
@ast
Clifton E Barry
@en
Clifton E Barry
@es
Clifton E Barry
@nl
Clifton E Barry
@sl
prefLabel
Clifton E Barry
@ast
Clifton E Barry
@en
Clifton E Barry
@es
Clifton E Barry
@nl
Clifton E Barry
@sl
P106
P21
P31
P496
0000-0002-2927-270X